Gov. Medical Malfeasance
Former State Pharmacist (Pennsylvania) Faces Criminal charges
Steven Fiorello, former Chief Pharmacist for the State of Pennsylvania, was arraigned on on Tuesday, November 21, 2006, on Felony and Misdemeanor charges related to his accepting money from drug companies whose drugs he put on the state Formulary.
Read MoreCholesterol Myths Debunked–Bad News for Statin Drug manufacturers
Cholesterol Myths Debunked–Bad News for Statin Drug manufacturers Fri, 11 Jul 2003 The demise of hormone replacement therapy (HRT) is not the only case of medical fraud perpetrated by the medical establishment whose practitioners’ professional judgment and clinical practice is too often guided by the pharmaceutical industry. A major scientific review of the cholesterol lowering…
Read MoreMore CDC Dirty Work re: ANTHRAX Vaccine – Meryl Nass, MD
More CDC Dirty Work re: ANTHRAX Vaccine – Meryl Nass, MD Wed, 20 Nov 2002 More indications that non-medical considerations are influencing the government’s anti-bioterrorism vaccine policy. In her column on RedFlags Weekly, Dr. Meryl Nass, board member of The Alliance for Human Research Protection, challenges the ethics of the newly revised anthrax vaccine trial…
Read MoreNIH AIDS Research Chief Rewrote Safety Report – AP
NIH AIDS Research Chief Rewrote Safety Report – AP Wed, 15 Dec 2004 John Solomon of The Associated Press continues his documented expose of the inner workings of the AIDS Division of theNational Institutes of Health (NIH). At the same time that the Los Angeles Times and Congfressional hearings focused on major conflicts of interest…
Read MoreAIDS Drug Experiments on Foster Care Children – A National Scandal
Wed, 04 May 2005 Researchers Tested AIDS Drugs on Children, Associated Press On March 10, 2004, The Alliance for Human Research Protection filed a complaint with the FDA and the federal Office of Human Research Protection about a series of AIDS drug experiments conducted on New York City children in foster care. That complaint prompted…
Read MoreAHRP Letter to Editor re: ARDS published NEJM
AHRP Letter to Editor re: ARDS published NEJM Fri, 11 Jul 2003 A truncated version of a Letter to the editor submitted by John H. Noble, Jr., PhD and Vera Sharav appears in the current July 10, 2003, issue of The New England Journal of Medicine. Note: On April 3, 2003 the NEJM published several…
Read MoreEthical Concerns Re: U.S. Sponsored Genetic Experiments in China
Commentary by Vera Hassner Sharav February 18, 2002 FYI United States Government Sponsored Genetic Research in Rural China Raises Troubling Ethical Concerns A January 2002 report in China Daily, byXiong Lei, the senior journalist with China Features, Xinhua News Agency(below), raises troubling ethical concerns about U.S. government-sponsoredgenetic research in rural China. The research under question…
Read MoreIndividuals Participating in the ARDS Network
http://hedwig.mgh.harvard.edu/ardsnet/faq.html#3 The individuals participating in the ARDS Network are listed below: Steering Committee Chair: Gordon Bernard, M.D., Vanderbilt University Clinical Coordinating Center: Massachusetts General Hospital: David Schoenfeld, Ph.D. B. Taylor Thompson, M.D. Nancy Ringwood, R.N., CCRA Cathryn Oldmixon, R.N. NHLBI Project Office: Andrea Harabin, Ph.D. Myron Waclawiw, Ph.D. Pamela Lew Clinical…
Read MoreGlaxo chief: "Our drugs do not work on most patients"
Glaxo chief: “Our drugs do not work on most patients” Mon, 8 Dec 2003 Dr. Allen Roses, worldwide vice-president of genetics at GlaxoSmithKline (GSK), Britain’s giant pharmaceutical company, acknowledged at a scientific meeting in London that fewer than half of the patients prescribed some of the most expensive drugs actually derived any benefit from them:…
Read MoreFormer FDA Chief Lied Under Oath Is Charged With Financial Conflict of Interest
Below the New York Times provides a summary of Crawford's selective disclosure and concealment of his financial holdings while he was
Commissioner, noting Crawford's ignoble tenure:
Industry Influence: FDA “Critical Path”/ Biased Research: BMJ / NIH: still smoke & mirrors
The battle lines were drawn between those who recognize the corrosive effect that the pharmaceutical industry is having on the safety and integrity of medicine and medical research, and the powerful stakeholders–the pharmaceutical-academic industrial complex.
Read MoreIOM Report Faults FDA Drug-Safety Process
A report by the Institute of Medicine is sharply critical of FDA’s drug safety monitoring system: "The report’s conclusions are striking and often damning – particularly when discussing the agency’s Center for Drug Evaluation and Research, known as C.D.E.R."
Read More